Novel Non-phosphorylated Serine 9/21 GSK3β/α Antibodies: Expanding the Tools for Studying GSK3 Regulation

por Grabinski, Tessa, Kanaan, Nicholas M.
Publicado en Front Mol Neurosci (2016)

Aging Does Not Affect Axon Initial Segment Structure and Somatic Localization of Tau Protein in Hippocampal Neurons of Fischer 344 Rats

por Kneynsberg, Andrew, Kanaan, Nicholas M.
Publicado en eNeuro (2017)

Exposure of the Amino Terminus of Tau Is a Pathological Event in Multiple Tauopathies

por Combs, Benjamin, Kanaan, Nicholas M.
Publicado en Am J Pathol (2017)

Neuronal and Glial Distribution of Tau Protein in the Adult Rat and Monkey

por Kanaan, Nicholas M., Grabinski, Tessa
Publicado en Front Mol Neurosci (2021)

Loss of Functional Alpha-Synuclein: A Toxic Event in Parkinson’s Disease?

por Kanaan, Nicholas M., Manfredsson, Fredric P.
Publicado en J Parkinsons Dis (2012)

Gene Therapy Models of Alzheimer’s Disease and Other Dementias

por Combs, Benjamin, Kneynsberg, Andrew, Kanaan, Nicholas M.
Publicado en Methods Mol Biol (2016)

Pathological conformations involving the amino terminus of tau occur early in Alzheimer’s disease and are differentially detected by monoclonal antibodies

por Combs, Benjamin, Hamel, Chelsey, Kanaan, Nicholas M.
Publicado en Neurobiol Dis (2016)

EFhd2 Affects Tau Liquid–Liquid Phase Separation

por Vega, Irving E., Umstead, Andrew, Kanaan, Nicholas M.
Publicado en Front Neurosci (2019)

Age-related changes in glial cells of dopamine midbrain subregions in rhesus monkeys

por Kanaan, Nicholas M., Kordower, Jeffrey H., Collier, Timothy J.
Publicado 2008

Ageing as a primary risk factor for Parkinson’s disease: evidence from studies of non-human primates

por Collier, Timothy J., Kanaan, Nicholas M., Kordower, Jeffrey H.
Publicado 2011

Age and Region-Specific Responses of Microglia, but not Astrocytes, Suggest a Role in Selective Vulnerability of Dopamine Neurons After 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine...

por KANAAN, NICHOLAS M., KORDOWER, JEFFREY H., COLLIER, TIMOTHY J.
Publicado 2008

Aging and Parkinson’s Disease: Different Sides of the Same Coin?

por Collier, Timothy J., Kanaan, Nicholas M., Kordower, Jeffrey H.
Publicado en Mov Disord (2017)

Production of recombinant tau oligomers in vitro

por Combs, Benjamin, Tiernan, Chelsea T., Hamel, Chelsey, Kanaan, Nicholas M.
Publicado en Methods Cell Biol (2017)

Liquid-liquid phase separation induces pathogenic tau conformations in vitro

por Kanaan, Nicholas M., Hamel, Chelsey, Grabinski, Tessa, Combs, Benjamin
Publicado en Nat Commun (2020)

A Method for Combining RNAscope In Situ Hybridization with Immunohistochemistry in Thick Free-Floating Brain Sections and Primary Neuronal Cultures

por Grabinski, Tessa M., Kneynsberg, Andrew, Manfredsson, Fredric P., Kanaan, Nicholas M.
Publicado en PLoS One (2015)

Quantitative and semi-quantitative measurements of axonal degeneration in tissue and primary neuron cultures

por Kneynsberg, Andrew, Collier, Timothy J., Manfredsson, Fredric P., Kanaan, Nicholas M.
Publicado en J Neurosci Methods (2016)

Axonal Degeneration in Tauopathies: Disease Relevance and Underlying Mechanisms

por Kneynsberg, Andrew, Combs, Benjamin, Christensen, Kyle, Morfini, Gerardo, Kanaan, Nicholas M.
Publicado en Front Neurosci (2017)

Tau Oligomer Pathology in Nucleus Basalis Neurons During the Progression of Alzheimer Disease

por Tiernan, Chelsea T, Mufson, Elliott J, Kanaan, Nicholas M, Counts, Scott E
Publicado en J Neuropathol Exp Neurol (2018)

Peroxynitrite Induced Nitrative and Oxidative Modifications Alter Tau Filament Formation

por Vana, Laurel, Kanaan, Nicholas M., Hakala, Kevin, Weintraub, Susan T., Binder, Lester I.
Publicado 2011

Pathogenic tau modifications occur in axons before the somatodendritic compartment in mossy fiber and Schaffer collateral pathways

por Christensen, Kyle R., Beach, Thomas G., Serrano, Geidy E., Kanaan, Nicholas M.
Publicado en Acta Neuropathol Commun (2019)